Diamonds and Dogs


Fitbit (FIT) a little bloated following the holidays. The wearable health and fitness tracking device maker is down following disappointing 2017 guidance, slower sales, and a structuring including a 6% cut to the workforce. Not a good way to start the New Year.

Not many stocks are trading higher today. Calithera Biosciences (CALA) is jumping 54% to a new high following a collaboration with Incyte Corp for a $45 million up-front investment and collaboration to develop & commercialize CB-1158 drug for attacking cancerous tumor cells. Good news for Calithera and patients.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.